Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3419239 | Revista Iberoamericana de Micología | 2006 | 11 Pages |
Abstract
Invasive fungal infections are important causes of morbidity and mortality in critically ill non neutropenic patients. For many years, amphotericin B and flucytosine have been the only available antifungal agents for invasive fungal infections. Fortunately, the antifungal armamentarium has increased during the past two decades with the addition of several new agents. In addition to itraconazole and fluconazole, lipid formulations of amphotericin B, voriconazole, and caspofungin have been recently licensed. These various antifungal agents differ in their pharmacokinetic and pharmacodynamic profile.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Mercedes Catalán, Juan Carlos Montejo,